DexCom (NASDAQ:DXCM) PT Raised to $163.00 at UBS Group : vim

DexCom (NASDAQ:DXCM – Get Free Report) had its target price lifted by equities research analysts at UBS Group from $153.00 to $163.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the medical device company’s stock. UBS Group’s price objective indicates a potential upside of […]

Related Keywords

Canada , United States , Raymond James , Stevenr Altman , Jeremem Sylvain , Oak Ridge Investments , Citigroup , Intelligence Driven Advisers , Partners Investment Advisory , Dexcom Company Profile , Wells Fargo Company , Dexcom Inc , Royal Bank , Get Free Report , Wells Fargo , Com Trading Down , Director Steven , Street Partners Investment Advisory , Driven Advisers , Bridge Investments , Dexcom Share , Dexcom Real Time , Dexcom Daily ,